跟读练习: Ataxia Series: Recognizing sporadic ataxias - 通过YouTube学习英语口语
C2
Hello and welcome to the MTS podcast,
235 句
如果句子过短或过长，请点击 Edit 进行调整。
1
Hello and welcome to the MTS podcast,
2
the official podcast of the International Parkinson's Movement Disorder Society.
3
I am Orlando Barsatini, Professor of Neurology at Federal University of Sao Paulo, Brazil.
4
And today I'm here with Dr. Divyan Gahr.
5
Dr. Divyan is Assistant Professor at the Department of Neurology of OutIndia Institute of Medical Science,
6
New Valley, India.
7
And today we are discussing sporadic ataxia you can't miss.
8
Divyanne, thank you for joining us.
9
Hi, Orlando.
10
Thank you for having me.
11
It's truly a pleasure to be here and to discuss such a clinically important topic.
12
Iviane, my first question, how do you clinically distinguish sporadic from genetic ataxias at the bedside?
13
And tell me about the diagnostic pitfalls you commonly see in the evaluation of sporadic ataxia.
14
a great starting point.
15
At the bedside, I focus on three pillars,
16
age at onset, the temporal profile of progression of symptoms,
17
and the family history.
18
So genetic ataxias usually tend to have an insidious onset.
19
They tend to be slowly progressive.
20
And sometimes we find additional neurological features like neuropathy,
21
pyramidal signs, movement disorders, vision involvement.
22
It is also important to remember that the absence of family history does not exclude a genetic cause,
23
which can be due to various reasons like incomplete penetrance,
24
inaccurate diagnosis in the family member,
25
subtle symptoms in the family,
26
or even a small family size or de novo mutations.
27
So sporadic ataxias, the clues to that are that they usually have an acute to subacute onset,
28
or they may have a very rapidly progressive course.
29
And sometimes we will find history of systemic symptoms or history of exposure to drugs,
30
toxins, which can be great clues.
31
And some of the common pitfalls include assuming that chronic invariably means degenerative ataxia.
32
That is not true because we know for many of these sporadic ataxias,
33
a longer history may still be a part of the clinical spectrum.
34
Another pitfall is to miss sensory ataxia and assume
35
that all ataxia is actually cerebellar because sensory ataxias have a different set of etiologies.
36
Another pitfall would be to overlook medications that patient may be on and not screening adequately for immune or metabolic causes.
37
So the key principle is to never label degenerative or hereditary before excluding treatable causes.
38
As you said, we have many groups,
39
many different groups of sporadic taxis,
40
including infectious, metabolic, and ultimune.
41
Could you talk a little bit more about the treatable forms?
42
Yes, Orlando, absolutely.
43
And this is really the heart of the matter
44
because sporadic ataxias should always be approached with the mindset that it may be treatable unless proven otherwise.
45
So the treatable causes, as you have mentioned,
46
can be broadly categorized into immune-mediated causes.
47
Particularly important in these are the anti-GAD-associated ataxia,
48
gluten ataxia, the paraneoplastic cerebellar degenerations,
49
The infectious causes which are continuing to be important in some parts of the world,
50
for example, ataxias occurring in the setting of HIV,
51
syphilis, Whipple's disease, and then the JC virus which can cause progressive malifocal leucal encephalopathy,
52
which can occur either in immunocompromised or immunocompetent settings.
53
And then in children, the post-infectious cerebellitis is important,
54
which can follow several viral infections.
55
And then metabolic and nutritional causes,
56
of course, you must always screen for vitamin deficiencies and some specific electrolyte disturbances.
57
Toxins are important, particularly alcohol continues to remain the most common cause globally.
58
But it is also important to consider certain medications,
59
particularly the anti-seizure medications, chemotherapy agents.
60
And last but not the least,
61
I would also mention the structural causes like the tumors,
62
strokes, demyelinating disorders like multiple sclerosis,
63
etc. because these can be remedied either surgically or medically.
64
So if I had to summarize the approach to treatable sporadic ataxias,
65
I would emphasize three clues.
66
Of course, the subacute or rapidly progressive temporal profile,
67
the presence of systemic or extracerebellar features,
68
and a disproportion between clinical severity and imaging,
69
which we can talk about a little later.
70
Okay.
71
Diviani, when should clinicians suspect immune-mediated cerebral arotaxis?
72
And could you mention some clinical or radiological clues for this vaginosis,
73
especially immune-mediated cerebral arotoxic?
74
Yeah.
75
This is a crucial question because immune-mediated cerebellar ataxias are actually a very time-sensitive and potentially treatable cause of sporadic ataxia.
76
The earlier we intervene in these conditions,
77
the better is the neurological outcome because once cerebellar atrophy becomes evident and established,
78
reversibility tends to decline significantly.
79
So the clinicians should suspect immune-mediated etiologies primarily when the evolution is subacute,
80
meaning the clinical symptoms progress over a few weeks to a few months.
81
So a patient may report a history that they were walking normally three months ago,
82
let's say, and they are now needing support.
83
So that should immediately raise concerns for a potential immune-mediated etiology.
84
Other clues could be a presence of a personal or a family history of autoimmune disorders.
85
For example, there could be a family member who has autoimmune thyroid disorders,
86
type 1 diabetes, vitiligo, pernicious anemia,
87
celiac disease, etc. And then if you have the presence of some other associated neurological features like seizures,
88
myoclonus, stiff person syndrome, peripheral neuropathy,
89
behavioral changes, all of these raise clinical clues towards suspecting immune-mediated cerebellar ataxias.
90
You also asked about the radiology.
91
So from the radiological standpoint,
92
there's an important teaching point that the MRI of the brain can actually be completely normal in the early stages.
93
So therefore, normal MRI does not exclude immune mediated etiologies.
94
Okay, great.
95
Divyani, sometimes gluten ataxia is a controversial topic.
96
What features suggest gluten ataxia?
97
And in your vision, what are the most important diagnostic and treatment challenges in gluten ataxia?
98
Yes, Orlando.
99
Gluten ataxia is indeed one of the most debated areas in sporadic ataxias.
100
I do agree with you.
101
So basically, it's an immune-mediated cerebellar condition which is triggered by gluten sensitivity and can often occur independent of the gastrointestinal symptoms.
102
In fact, many patients may not have the classic features of celiac disease.
103
Clinically, one can suspect gluten ataxia in somebody who has a sporadic progressive cerebellar condition with predominantly a midline ataxia.
104
So there is predominantly gait and truncal ataxia,
105
a relatively pure cerebellar syndrome,
106
or sometimes one may have coexisting peripheral neuropathy or myoclonus.
107
The MRI may show vermeon predominant atrophy,
108
but as I told you earlier,
109
the early imaging may be normal.
110
So a good clue here becomes to look at the MR spectroscopy of the vermis,
111
which may show a reduced NAA is to creatinine ratio.
112
And like you mentioned, the challenges are actually substantial in gluten ataxia.
113
The antibody testing is imperfect.
114
We rely on a whole host of antibodies
115
and there is a lot of debate about which antibodies are most neurologically relevant as opposed to most gastrointestinally relevant.
116
Then there are patients who may be zero negative but they are very clinically concerning for gluten.
117
So this may raise challenges about whether to initiate a strict gluten-free diet
118
or not and there are no universally standardized diagnostic criteria for gluten ataxia.
119
So that creates a problem itself.
120
Diviani, now I have another sensitive point in the study of ataxia.
121
What pathophysiological mechanism explains selective cerebellar degenerative in nutritional deficient related A-tacta?
122
And which deficients are the most frequently overlooked in the clinical practice?
123
This is a fascinating and a very important area.
124
So the cerebellum, as you know,
125
especially the the Purkinje cells,
126
they are metabolically highly active and they are particularly vulnerable to metabolic stress.
127
So these neurons have extensive dendritic connections and they have very high firing rates.
128
So that makes them especially sensitive to mitochondrial dysfunction,
129
oxidative stress or any other form of energy deficit.
130
So nutritional deficiencies tend to interfere either directly or indirectly with these pathways.
131
And some of the commoner nutritional deficiencies are triggered by thymine deficiency
132
that may occur in the setting of chronic alcohol use but that's pretty well known.
133
But some of the less common or overlooked deficiencies might be deficiency of vitamin b12,
134
copper and vitamin E all of which tend to cause sensory ataxia rather than cerebellar ataxia.
135
And another important deficiency which we should think of particularly
136
when there is a setting of chronic vomiting or proton pump inhibitor use
137
or a GI surgery would be a deficiency of magnesium.
138
And this is a really important cause of cerebellar ataxia,
139
where patients can present with severe ataxia,
140
classically with a downbeating nystagmus.
141
And the MRI may show a typical involvement of the nodulus,
142
or it may show cerebellar vasogenic edema.
143
It's really important to recognize magnesium deficiency because quick supplementation can lead to dramatic recovery.
144
Divini, another important point is sporadic cataxia are quite complex.
145
Which toxic or drug-induced ataxia are commonly overlooked in the clinical practice.
146
I believe that this is a quite important point.
147
I absolutely agree with you because drug-induced and toxic ataxias are probably more common than we recognize,
148
and they are very frequently reversible if they're recognized early.
149
So, of course, chronic alcohol exposure,
150
it is difficult to overlook it,
151
but sometimes patients may minimize intake,
152
So it's important to be careful and take a non-judgmental history.
153
It's important to recognize this because it can lead to permanent cerebellar damage, alcoholic cerebellar degeneration.
154
But in terms of the drug,
155
some of the important drugs that I want to talk about are the anti-seizure medications.
156
So we do know that the older generation anti-seizure medications like phenytoin,
157
babichirates, benzodiazepines, and all of that can result in cerebellar atrophy.
158
And they continue to be used in many regions of the world.
159
So chronic exposure to these can lead to permanent cerebellar atrophy.
160
But even among the newer antiseizure medications like gabapentin,
161
pregabalin, lamotrigine, many of them are known to trigger ataxia,
162
vertigo, tremors as side effects.
163
The other group of drugs that we must not miss is antibiotics,
164
particularly metronirazole, because that is often used for gastrointestinal infections.
165
and a high cumulative dose can precipitate subacute cerebellar syndromes.
166
And then sometimes we have clear exposures to drugs like lithium,
167
chemotherapeutic agents like cytarabine and immune checkpoint inhibitors increasingly that are being used for the treatment of cancer.
168
And then in certain occupations,
169
one can have heavy metal exposures like mercury or lead.
170
So these might be some of the overlooked causes,
171
but definitely are eminently reversible with reduction of exposure.
172
Divini, how do sensory neuronopathy-associated ataxia alter the diagnostic approach compared,
173
for example, with pure cerebellar syndromes?
174
This is a very relevant question clinically,
175
because profound proprioceptive loss can mimic cerebellar ataxia,
176
but the close there would be a worsening of the ataxia in darkness,
177
presence of pseudoathetosis and importantly there would be a preservation of the eye movements in speech
178
because these two latter are mediated directly by the cerebellum
179
so we don't expect these to be abnormal in a proprioceptive pathway dysfunction.
180
Nerve conduction studies are essential and it's important to differentiate clinically sensory from cerebellar ataxias
181
because of the list of causes for sensory neuronopathy.
182
So the usual causes include paraneoplastic syndromes,
183
Jogren's syndrome, chemotherapy agents, B12 deficiency,
184
and increasingly being recognize the immune mediated neuropathies like the nodalopathies and the paranodalopathies.
185
So recognizing sensory ataxia actually shifts the diagnostic work up towards peripheral and systemic causes.
186
And which systemic alt-immune or endocrine disorder should be routinely screened for an ex-premate sporoidic ataxia?
187
So this really depends on the clinical context,
188
but I would routinely screen for thyroid dysfunction,
189
antithyroid antibodies, celiac serology, anti-GAD antibodies,
190
and then the autoimmune markers,
191
paraneoplastic markers, HIV serology, and B12 deficiency.
192
So these are relatively low cost tests with a high diagnostic yield in selected patients.
193
So this would be a very basic screening for sporadic ataxias.
194
Okay.
195
And regarding treatment, which clinical or biomarker features predict the immunotherapy response in all the new cerebellar attacks, the DVNA.
196
This is a very important question,
197
Orlando, because I just want to mention that time is cerebellum.
198
So when we initiate therapy early,
199
there is a potential to salvage the cerebellar reserve and improve the neurological deficits.
200
The predictors to response to immunotherapy,
201
as you asked, would include a shorter duration of symptoms,
202
a subacute onset, presence of an MRI being normal rather than an MRI showing cerebellar atrophy,
203
presence of surface antibodies as compared to the intracellular onconeural antibodies,
204
and of course, early treatment initiation.
205
Okay.
206
Divyami, this is my last question.
207
It's probably the most important question.
208
What is the diagnostic algorithm for sporadic ataxia that the treatable ones are not missing?
209
I think this is the core question.
210
So my structured approach is to first confirm whether it's a cerebellar ataxia or a sensory ataxia or a vestibular ataxia.
211
This would of course be deciphered by a good history and a clinical examination.
212
Determine the temporal profile and progression of symptoms,
213
whether it's are rapidly progressive, subacute.
214
Then take a targeted history of exposure to drugs and toxins.
215
Don't forget this because this sometimes gets overlooked.
216
Perform a good MRI of the brain.
217
You must also try to see whether radiological involvement is proportionate to the degree of clinical involvement
218
because if you find a lot of clinical dysfunction but not so much of radiological findings,
219
that's a good clue towards thinking of immune-mediated ataxias.
220
Order some basic laboratory screening like we mentioned earlier,
221
that is the routines, thyroid functions, vitamin levels.
222
Then pursue targeted autoimmune, paraneoplastic,
223
or infectious testing depending on the clinical context.
224
Also consider genetic testing only after these treatable causes are excluded.
225
So the guiding principle is simple,
226
exclude reversible causes before labeling the patient with a degenerative disorder.
227
Okay, thank you Diviani for sharing these insights and thank you to our listeners for joining us.
228
We hope this episode helped you approach sporadic attacks with greater confidence and precision.
229
Thank you.
230
Thank you, Orlando.
231
The views
232
and opinions expressed by the participants in this podcast do not necessarily reflect those of the International Parkinson
233
and Movement Disorders Society or their affiliated journals,
234
Movement Disorders and Movement Disorders Clinical Practice.
235
Any disclosures of the participants can be found within the episode description located on the MDS website.
下载应用
AI 为你说出的每个句子打分
TRENDING
热门
背景与背景
在本期 MTS 播客中，来自巴西圣保罗联邦大学的神经学教授 Orlando Barsatini 与印度新德里 OutIndia 医科学院的助理教授 Divyan Gahr 一起讨论了 间歇性共济失调 的临床识别。这一话题具有重要的临床意义，尤其是在帮助患者确诊和治疗方面。专家们深入探讨了如何在临床环境中区分遗传性与散发性的共济失调，并提供了关键的诊断线索。
日常交流的五个重要短语
- 间歇性共济失调： 是一种临床表现，临床医生需要正确诊断。
- 吸引眼球的症状： 注意并记录其他系统症状可能提供重要线索。
- 药物暴露： 有些药物可能导致类似共济失调的症状。
- 免疫介导的原因： 例如，抗 GAD 相关的共济失调和谷蛋白共济失调。
- 可治疗的形式： 除了遗传性共济失调，也存在其他可治疗的病因。
逐步跟读指南
提高 英语发音 的有效方法之一是通过跟读（shadowing）。以下是基于本期播客的跟读步骤：
- 选择片段： 从视频中选择一小段，例如关于“诊断误区”的讨论，用于跟读。
- 反复收听： 多次听取选定的片段，确保理解每个单词的发音和语调。
- 跟读练习： 同时播放音频并模仿说话者的发音和节奏，注重语音的流利度和准确性。
- 录音对比： 自己录音，并与原始音频进行对比，找出差异并加以改正。
- 逐步提高： 随着自信心提高，逐渐增加跟读的段落长度，甚至引入更多复杂的内容，如科学讨论。
通过使用这种 shadow speech 技巧，你会逐渐提高口语能力，特别是在 雅思口语练习 中，这种能力尤为重要。记住，跟读并不只是机械模仿，而是要内化语言的节奏与情感，达到更好的语言表达效果。
什么是跟读法？
跟读法 (Shadowing) 是一种有科学依据的语言学习技巧，最初开发用于专业口译员的培训，并由多语言者Alexander Arguelles博士普及。这个方法简单而强大：您在听英语母语原声的同时立即大声重复——就像是一个延迟1-2秒紧跟说话者的影子。与被动听力或语法练习不同，跟读法强迫您的大脑和口腔肌肉同时处理并模仿真实的讲话模式。研究表明它能显着提高发音准确性，语调，节奏，连读，听力理解和口语流利度——使其成为雅思口语备考和真实英语交流最有效的方法之一。